Syngene International Ltd Q4 FY2023|24 Earnings Conference Call

Syngene International Q4 Results | Profit up 6% to ₹189 crore ...

The company's EBITDA rose 0.9% to ₹316.9 crore in the fourth quarter of this fiscal over ₹314.1 crore in Q4 of FY23. Shares of Syngene ...

“Syngene International Limited Q2 and H1 FY'25 Results ...

Moderator: Ladies and gentlemen, good day, and welcome to Syngene International's Second Quarter FY. 2025 Financial Results Conference Call.

Syngene International Ltd Q2 FY2024-25 Earnings Conference Call

Syngene International Ltd Q2 FY2024-25 Earnings Conference Call. 1 watching now ...more. AlphaStreet India. 37.3K. Subscribe. 0. Share. Save.

Syngene International Quarterly Results, Syngene ... - Moneycontrol

Financials ; Quarterly Results of Syngene International (in Rs. Cr.) Sep '24, Jun '24 ; Net Sales/Income from operations, 821.30, 726.50 ; Other Operating Income ...

Syngene Q4FY22 Earnings Call Transcript | PDF | Investing - Scribd

International held an investor conference call to discuss their Q4 FY2022 financial ... Syngene International Limited : Putting Science to Work PAGE 1.

SYNGENE INTERNATIONAL LTD. : Latest Quarterly Results Analysis

Revenue from operations increased sequentially by 13% QoQ to Rs 891 crore in Q2FY25, change -2% YoY compared to Rs 910 crore during Q2FY24. H1FY25 revenue was ...

Syngene International Q4 Results 2024 - Mint

Operating Income, 215.80, 152.00 ; Net Income Before Taxes, 209.00, 139.90 ; Net Income, 188.60, 109.70 ; Diluted Normalized EPS, 4.69, 2.71 ...

Share holder services - Syngene International Ltd

Details of equity shares liable to be transferred to IEPF – Dividend FY 2016-17. Open. FY 2023. Annual General Meeting. AGM 2023 Recordings.

Earnings Call Transcripts - Global Biopharmaceutical company

FY 2021 - 22 · Q1 · Biocon Biologics – Serum Institute Life Sciences Collaboration Conference Call Transcript · Q2 · Q3 · Biocon Biologics' acquisition of ...

Syngene International Share Price - The Economic Times

Syngene Int. Share Price Forecast · 8 analysts have given an average revenue target of Rs. 3597.07 Cr. for Syngene International Ltd in FY24. · Syngene ...

Syngene International Ltd Q1 FY23 Earnings Conference Call Insights

https://youtu.be/xL_nlERmIDQ Key highlights from Syngene International Ltd (SYNGENE) Q1 FY23 Earnings Concall Q&A Highlights: Prakash ...

SYNGENE INTERNATIONAL LIMITED - SEBI

5% of the QIB. Portion (excluding the Anchor Investor Portion) shall be available for allocation on a proportionate basis to Mutual Funds only, and the ...

Syngene International Ltd share price | About Syngene Intl. - Screener

Stock is trading at 7.89 times its book value · Company has a low return on equity of 13.5% over last 3 years. · Dividend payout has been low at 10.3% of profits ...

Q2 2025 Syngene International Ltd Earnings Call Transcript

Oct 24, 2024 / 08:30AM GMTOperator Ladies and gentlemen ... Syngene International second quarter FY2025 financial results conference call.

Syngene Q1 Results: Net profit drops 19% to Rs 76 crore

Syngene International, the contract research and manufacturing services arm of Biocon, reported 19% year-on-year (YoY) drop in net profit to ...

Syngene International News - The Economic Times

... transcript of the Q2 FY2025 Earnings Call conducted on October 24, 2024 and uploaded on the Company's website. Announcement under Regulation 30 (LODR)- ...

Srishti Ramesh Kaushik - Indegene

Ladies and gentlemen, good day and welcome to Indegene Limited Q4 FY '24 Earnings. Conference Call. As a reminder, all participant lines will be ...

Syngene International Limited (SYNGENE.BO) - Yahoo Finance

Find the latest Syngene International Limited (SYNGENE.BO) stock quote, history, news and other vital information to help you with your stock trading and ...

Stock Exchange Disclosures - Syngene International Ltd

Name: Intimation of receipt of the order regarding refund from the Income Tax Department. Open. Intimation of submission of a Writ Petition against Income ...

Biocon Q4FY24 Revenue at Rs 3966 Cr, EBITDA at Rs 964 Cr

“For the full year FY24, we reported consolidated revenue growth of 35% at Rs 15,621 crore and an EBITDA growth of 44 % at Rs 4,164 crore with ...